BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 26545605)

  • 1. Formulation and comparative evaluation of HPMC and water soluble chitosan-based sparfloxacin nanosuspension for ophthalmic delivery.
    Ambhore NP; Dandagi PM; Gadad AP
    Drug Deliv Transl Res; 2016 Feb; 6(1):48-56. PubMed ID: 26545605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sparfloxacin-loaded PLGA nanoparticles for sustained ocular drug delivery.
    Gupta H; Aqil M; Khar RK; Ali A; Bhatnagar A; Mittal G
    Nanomedicine; 2010 Apr; 6(2):324-33. PubMed ID: 19857606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biodegradable levofloxacin nanoparticles for sustained ocular drug delivery.
    Gupta H; Aqil M; Khar RK; Ali A; Bhatnagar A; Mittal G
    J Drug Target; 2011 Jul; 19(6):409-17. PubMed ID: 20678034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Moxifloxacin loaded gelatin nanoparticles for ocular delivery: Formulation and in-vitro, in-vivo evaluation.
    Mahor A; Prajapati SK; Verma A; Gupta R; Iyer AK; Kesharwani P
    J Colloid Interface Sci; 2016 Dec; 483():132-138. PubMed ID: 27552421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of pluronic nanosuspensions loading a novel insoluble anticancer drug both in vitro and in vivo.
    Tang XJ; Fu YH; Meng QH; Li LM; Ying XY; Han M; He QJ; Yang B; Zeng S; Hu YZ; Sheng XX; Gao JQ
    Int J Pharm; 2013 Nov; 456(1):243-50. PubMed ID: 23928148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formulation and development of ophthalmic in situ gel for the treatment ocular inflammation and infection using application of quality by design concept.
    Patel N; Thakkar V; Metalia V; Baldaniya L; Gandhi T; Gohel M
    Drug Dev Ind Pharm; 2016 Sep; 42(9):1406-23. PubMed ID: 26716613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Novel Method for Preparing Surface-Modified Fluocinolone Acetonide Loaded PLGA Nanoparticles for Ocular Use: In Vitro and In Vivo Evaluations.
    Salama AH; Mahmoud AA; Kamel R
    AAPS PharmSciTech; 2016 Oct; 17(5):1159-72. PubMed ID: 26589410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanoparticle-Based Topical Ophthalmic Gel Formulation for Sustained Release of Hydrocortisone Butyrate.
    Yang X; Trinh HM; Agrahari V; Sheng Y; Pal D; Mitra AK
    AAPS PharmSciTech; 2016 Apr; 17(2):294-306. PubMed ID: 26085051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and optimization of controlled release bioerodable anti infective ophthalmic insert.
    Thakur R; Swami G; Rahman M
    Curr Drug Deliv; 2014; 11(1):2-10. PubMed ID: 22283654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statistical optimization of voriconazole nanoparticles loaded carboxymethyl chitosan-poloxamer based in situ gel for ocular delivery: In vitro, ex vivo, and toxicity assessment.
    Pardeshi SR; More MP; Patil PB; Mujumdar A; Naik JB
    Drug Deliv Transl Res; 2022 Dec; 12(12):3063-3082. PubMed ID: 35525868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chitosan/sulfobutylether-β-cyclodextrin nanoparticles as a potential approach for ocular drug delivery.
    Mahmoud AA; El-Feky GS; Kamel R; Awad GE
    Int J Pharm; 2011 Jul; 413(1-2):229-36. PubMed ID: 21540097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a novel ophthalmic ciclosporin A-loaded nanosuspension using top-down media milling methods.
    Kim JH; Jang SW; Han SD; Hwang HD; Choi HG
    Pharmazie; 2011 Jul; 66(7):491-5. PubMed ID: 21812323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of Timolol-Loaded Galactosylated Chitosan Nanoparticles and Evaluation of Their Potential for Ocular Drug Delivery.
    Zhao R; Li J; Wang J; Yin Z; Zhu Y; Liu W
    AAPS PharmSciTech; 2017 May; 18(4):997-1008. PubMed ID: 28101726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and in vitro/in vivo evaluation of HPMC/chitosan gel containing simvastatin loaded self-assembled nanomicelles as a potent wound healing agent.
    Varshosaz J; Taymouri S; Minaiyan M; Rastegarnasab F; Baradaran A
    Drug Dev Ind Pharm; 2018 Feb; 44(2):276-288. PubMed ID: 29043860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glabridin nanosuspension for enhanced skin penetration: formulation optimization, in vitro and in vivo evaluation.
    Wang WP; Hul J; Sui H; Zhao YS; Feng J; Liu C
    Pharmazie; 2016 May; 71(5):252-7. PubMed ID: 27348968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of tropicamide-loaded tamarind seed xyloglucan nanoaggregates for ophthalmic delivery.
    Dilbaghi N; Kaur H; Ahuja M; Kumar S
    Carbohydr Polym; 2013 Apr; 94(1):286-91. PubMed ID: 23544540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanocrystal-based drug delivery system of risperidone: lyophilization and characterization.
    Gol D; Thakkar S; Misra M
    Drug Dev Ind Pharm; 2018 Sep; 44(9):1458-1466. PubMed ID: 29619857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and Evaluation of Diclofenac Sodium Loaded-N-Trimethyl Chitosan Nanoparticles for Ophthalmic Use.
    Asasutjarit R; Theerachayanan T; Kewsuwan P; Veeranodha S; Fuongfuchat A; Ritthidej GC
    AAPS PharmSciTech; 2015 Oct; 16(5):1013-24. PubMed ID: 25609376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design of selegiline-loaded bio-nanosuspension for the management of depression using novel bio-retardant from
    Tyagi Y; Madhav NVS
    Drug Dev Ind Pharm; 2019 Aug; 45(8):1351-1360. PubMed ID: 31084445
    [No Abstract]   [Full Text] [Related]  

  • 20. Formulation of Chitosan Polymeric Vesicles of Ciprofloxacin for Ocular Delivery: Box-Behnken Optimization, In Vitro Characterization, HET-CAM Irritation, and Antimicrobial Assessment.
    Ameeduzzafar ; Alruwaili NK; Imam SS; Alotaibi NH; Alhakamy NA; Alharbi KS; Alshehri S; Afzal M; Alenezi SK; Bukhari SNA
    AAPS PharmSciTech; 2020 Jun; 21(5):167. PubMed ID: 32504176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.